Patient beliefs about chemotherapy, cancer influence care choices at the end of life
the ONA take:
In an assessment of the impact of patients’ beliefs on their choices for care at the end of life, researchers found that patients with advanced cancer who believed chemotherapy might cure their cancer were more likely to receive chemotherapy in the last month of life and less likely to enroll in hospice care before death.
The study examined 722 patients with stage IV lung or colorectal cancer who completed a baseline survey and died during the study period.
The association of understanding goals for chemotherapy with its use in the last month of life and hospice enrollment before death was assessed using logistic regression. One-third of the patients understood that chemotherapy was “not at all” likely to cure their cancer.
However, use of chemotherapy among these patients was similar to that of other patients at end of life.
The study concludes that patients with advanced cancer who were well informed about chemotherapy's goals received late-life chemotherapy at rates similar to those for other patients. However, understanding the incurable nature of cancer is associated with increased hospice enrollment before death.
Patients with advanced cancer who believed chemotherapy might cure their cancer were more likely to receive chemotherapy.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|